Giuseppe Saltalamacchia

Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions

Riccardo Gerosa, Rita De Sanctis, Flavia Jacobs et al. · Critical Reviews in Oncology/Hematology · 2024 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +17

Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy)

Erica Quaquarini, Giuseppe Saltalamacchia, Daniele Presti et al. · Cancers · 2020 · 52 citations · Full text

Medicine, Infectious Disease Control, Oncology +17

Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study

Raffaella Palumbo, Rosalba Torrisi, Federico Sottotetti et al. · Therapeutic Advances in Medical Oncology · 2021 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

Esophageal cancer mortality: Relationship with alcohol intake and cigarette smoking in Italy

Francesco La Rosa, Alberto Cresci, Carla Orpianesi et al. · European Journal of Epidemiology · 1988 · 10 citations

Medicine, Health Sciences, Oncology +13